How many insider declarations does Milestone Pharmaceuticals Inc. have?

Milestone Pharmaceuticals Inc. has filed 1 insider declaration with SEC (Form 4).

Who is the top reporting insider at Milestone Pharmaceuticals Inc.?

The top reporting insider at Milestone Pharmaceuticals Inc. is TRUEX PAUL F, based on the count of public filings.

Across the available history, declared buys total 0 and disposals 0.

FY ended December 2025 · cache

1.50 €

Analyst consensus

6 analysts

Strong buy

2.00 €Target 6.33 €(+324%)8.00 €

Income statement

Revenue1.5 M€

Net income−63.1 M€-4078.8% margin

Valuation

PER (forward)-1.4x

P/Book4.4x

Beta1.04

Balance sheet & cash

Market cap178.9 M€

Total debt58.4 M€

Free Cash Flow−49.3 M€

Debt / Equity140%

Profitability & ownership

ROE-229.7%

ROA-41.1%

% insiders2.5%

% institutions25.0%

Last declaration on 1 June 2022